California is investing $500M in therapy apps for youth. Advocates fear it won’t pay off.

Mem­bers of the House on both sides of the aisle joined with Sen­ate col­leagues late last month in rein­tro­duc­ing a bill that would al­low for

By Vivienne Raper, PhD Emerging biologics such as multispecific antibodies, mRNA vaccines, and viral vector–based gene therapies are more complex than established biologics such as

Pfiz­er and BioN­Tech re­spond­ed to a patent in­fringe­ment suit filed by Ar­bu­tus Bio­phar­ma and Genevant, deny­ing the ac­cu­sa­tion that their Covid-19 vac­cine in­fringed on patents